Jacobson PA - Search Results

1

Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation.

Jacobson PA, Schladt D, Oetting WS, Leduc R, Guan W, Matas AJ, Lamba V, Mannon RB, Julian BA, Israni A; DeKAF investigators. Jacobson PA, et al. Transplantation. 2011 Feb 15;91(3):309-16. doi: 10.1097/TP.0b013e318200e971. Transplantation. 2011. PMID: 21107304 Free PMC article.

2

Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.

Jacobson PA, Ng J, Green KG, Rogosheske J, Brundage R. Jacobson PA, et al. Biol Blood Marrow Transplant. 2003 May;9(5):304-11. doi: 10.1016/s1083-8791(03)00076-4. Biol Blood Marrow Transplant. 2003. PMID: 12766880 Free article.

3

Mycophenolate mofetil in islet cell transplant: variable pharmacokinetics but good correlation between total and unbound concentrations.

Jacobson PA, Green KG, Hering BJ. Jacobson PA, et al. J Clin Pharmacol. 2005 Aug;45(8):901-9. doi: 10.1177/0091270005278599. J Clin Pharmacol. 2005. PMID: 16027400

4

Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation.

Jacobson P, Rogosheske J, Barker JN, Green K, Ng J, Weisdorf D, Tan Y, Long J, Remmel R, Sawchuk R, McGlave P. Jacobson P, et al. Clin Pharmacol Ther. 2005 Nov;78(5):486-500. doi: 10.1016/j.clpt.2005.08.009. Clin Pharmacol Ther. 2005. PMID: 16321615

5

High unbound mycophenolic acid concentrations in a hematopoietic cell transplantation patient with sepsis and renal and hepatic dysfunction.

Jacobson P, Long J, Rogosheske J, Brunstein C, Weisdorf D. Jacobson P, et al. Biol Blood Marrow Transplant. 2005 Dec;11(12):977-8. doi: 10.1016/j.bbmt.2005.08.037. Biol Blood Marrow Transplant. 2005. PMID: 16338619 Free article. No abstract available.

6

Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation.

Jacobson P, Green K, Rogosheske J, Brunstein C, Ebeling B, DeFor T, McGlave P, Weisdorf D. Jacobson P, et al. J Clin Pharmacol. 2007 Jan;47(1):6-12. doi: 10.1177/0091270006295064. J Clin Pharmacol. 2007. PMID: 17192496 Clinical Trial.

7

Higher mycophenolate dose requirements in children undergoing hematopoietic cell transplant (HCT).

Jacobson P, Huang J, Rydholm N, Tran M, Defor T, Tolar J, Orchard PJ. Jacobson P, et al. J Clin Pharmacol. 2008 Apr;48(4):485-94. doi: 10.1177/0091270007313326. Epub 2008 Feb 22. J Clin Pharmacol. 2008. PMID: 18296555

8

Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.

Johnson LA, Oetting WS, Basu S, Prausa S, Matas A, Jacobson PA. Johnson LA, et al. Among authors: jacobson pa. Eur J Clin Pharmacol. 2008 Nov;64(11):1047-56. doi: 10.1007/s00228-008-0501-y. Epub 2008 Jun 21. Eur J Clin Pharmacol. 2008. PMID: 18568343

9

Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation.

Jacobson P, El-Massah SF, Rogosheske J, Kerr A, Long-Boyle J, DeFor T, Jennissen C, Brunstein C, Wagner J, Tomblyn M, Weisdorf D. Jacobson P, et al. Bone Marrow Transplant. 2009 Jul;44(2):113-20. doi: 10.1038/bmt.2008.428. Epub 2009 Jan 19. Bone Marrow Transplant. 2009. PMID: 19151792 Free PMC article. Clinical Trial.

10

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.

Jacobson PA, Huang J, Wu J, Kim M, Logan B, Alousi A, Grimley M, Bolaños-Meade J, Ho V, Levine JE, Weisdorf D. Jacobson PA, et al. Biol Blood Marrow Transplant. 2010 Mar;16(3):421-9. doi: 10.1016/j.bbmt.2009.11.010. Biol Blood Marrow Transplant. 2010. PMID: 19925875 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page